Mumbai, the pharmaceutical destination in India , is home to several key H2-receptor antagonist Active Pharmaceutical Ingredient (API) manufacturers . These entities, specializing in the production of cimetidine hydrochloride (CAS No 51481-61-9), supply both domestic and international markets. Leading players in this space feature firms known for t